Economics and International Affairs Blog
A blog by Vivekanand Jayakumar
Attention Economy
Thursday, April 4, 2024
Who Pays for Ozempic?
Can Ozempic be a breakthrough drug and overpriced at the same time?
https://www.vox.com/future-perfect/2024/4/3/24119220/ozempic-wegovy-weight-loss-medicare-coverage-price
Millions of Medicare patients could soon be prescribed Wegovy — and it’s going to cost taxpayers a lot of money.
Newer Post
Older Post
Home
The Danish Approach to Capitalism
Trump's Tariff Proposals - A Cause for Concern?
The ROW Seeks an Alternative to the Dollar Standard